Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g. NEAR(recruit, professionals, 20)).
Finds documents with the search term in word versions or composites. The asterisk * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g. lightweight*, *lightweight, *lightweight*).
Continuous glucose monitoring reduces the risk for hospitalization and mortality versus self-monitoring in insulin-treated older adults with diabetes and dementia.
Exocrine pancreatic insufficiency has various causes that differ with age, and diagnosis is challenging due to the lack of reliable diagnostic testing approaches. A high index of suspicion based on clinical history should inform testing.
IL-17A is gaining recognition for its potential role in DKD and could represent a promising therapeutic target. Examine the latest research findings and potential mechanisms underlying the cytokine’s involvement in DKD.
Emerging evidence highlights ferroptosis as a key player in the progression of diabetic cardiomyopathy. Discover the mechanistic links between ferroptosis and DCM, and the promising therapeutic strategies targeting them.
Explore the recommendations from the European Diabetes Forum working group, convened to examine good diabetes care in the context of AI-driven clinical decision support systems.
In 2005 the US FDA approved the first GLP-1 medicine for type 2 diabetes, marking the start of a remarkable journey that goes beyond the stimulation of insulin secretion.
Prof. Daniel Drucker gives us a fascinating insight into the early work on GLP-1 and discusses how these medicines are impacting the lives of people with diabetes and obesity. He covers what's known about how they work, treatment duration, side effects, and the role of bariatric surgery, plus what's in the pipeline in terms of drug development and the indications that GLP-1 medicines may be used to treat in the future.
Obesity is a major contributor to cardiorenal metabolic disease, but its impact extends throughout the body. Understand how obesity can affect other organ systems and impact treatment, and whether weight-loss measures improve outcomes.
What could be causing involuntary and uncontrolled movements in the right arm and leg of a woman with a 25-year history of diabetes and hypertension, beginning shortly after an intramuscular betamethasone injection for shoulder pain?
A man who achieved diabetes remission after gastric bypass presented with hypoglycemic episodes and endogenous hyperinsulinemia. Hypoglycemia resolved and fasting tests normalized when sacubitril/valsartan was discontinued due to worsening renal function.
A woman with abdominal pain was diagnosed with ureteral stones, but her pain persisted despite stent placement. A prior diagnosis of type 2 diabetes led to diabetic ketoacidosis being identified as the cause of the pain.
Prof. Chantal Mathieu highlights how the absence of rigorous performance standards for continuous glucose monitors in Europe contributes to wide variability in device accuracy, raising important concerns about patient safety.
Sequential addition of oral glucose-lowering therapies, insulin or incretin-based therapy is often required to attain optimal glycemic control and reduce the risk of diabetes-associated complications. Despite advances in treatment, a large …
Diabetic peripheral neuropathy (DPN) is one of the most significant chronic complications in people with diabetes. It is a highly heterogeneous condition that affects various parts of the nervous system and presents with a wide range of symptoms.
The prevalence of diabetes is rising among older adults. While most diabetes cases in older adults are type 2 diabetes mellitus (T2D), advances in type 1 diabetes mellitus (T1D) management and rising rates of adult-onset T1D have translated into a …
Glucagon-like peptide-1 receptor agonists (GLP-1RAs)—along with the dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1RA tirzepatide—are widely acknowledged for their efficacy in managing both type 2 diabetes mellitus and obesity, with …
Familiarize yourself with current and emerging ketone monitoring systems and the most useful clinical scenarios in which to use them through our podcasts and e-learning modules. Lower the barriers to effective prevention of diabetic ketoacidosis.
Prof. Chantal Mathieu highlights how the absence of rigorous performance standards for continuous glucose monitors in Europe contributes to wide variability in device accuracy, raising important concerns about patient safety.
Refine the application of CGM technology in primary care to enhance the management of type 2 diabetes. Benefit from key updates and experiential learning using CGM devices, and practice your clinical decision-making skills with real cases, vodcasts, and interactive infographics.
Nearly half of patients with acute large vessel occlusion (LVO) fail to achieve functional independence following endovascular therapy (EVT) [ 1 ], prompting a recent research focus on adjuvant treatment strategies [ 2 ]. Hyperglycemia at admission …
Gestational diabetes mellitus (GDM) is any degree of glucose intolerance with onset or first recognition during pregnancy that does not fulfill the criteria of overt diabetes [ 1 ]. GDM is characterized by increased insulin resistance and/or …
This article is published with digital features, including a Graphical Abstract to facilitate understanding of the article. To view digital features for this article go to https://doi.org/10.6084/m9.figshare.30580040 .
Telomere length (TL) is a marker of cellular aging. Telomeres, located at the ends of chromosomes, contain sequence repeats (TTAGGG) and are necessary to maintain genome integrity [ 1 ]. Due to the fact that telomerase is not active in most somatic …
Continuous glucose monitoring reduces the risk for hospitalization and mortality versus self-monitoring in insulin-treated older adults with diabetes and dementia.
Continuous glucose monitoring reduces the risk for hospitalization and mortality versus self-monitoring in insulin-treated older adults with diabetes and dementia.
IL-17A is gaining recognition for its potential role in DKD and could represent a promising therapeutic target. Examine the latest research findings and potential mechanisms underlying the cytokine’s involvement in DKD.
Continuous glucose monitoring reduces the risk for hospitalization and mortality versus self-monitoring in insulin-treated older adults with diabetes and dementia.